Antibiotic Resistance on the Rise: Australia’s Alarming Health Crisis Revealed
The Australian Centre for Disease Control (CDC) has just dropped a bombshell: the Sixth Australian Report on Antimicrobial Use and Resistance in Human Health (AURA Report), and the findings are both eye-opening and deeply concerning. But here’s where it gets controversial: while overall antibiotic use has dropped by 21% over the past decade, critical cases of antibiotic resistance surged by a staggering 25% in 2024. And this is the part most people miss: less than half of the antibiotics given after surgeries were deemed appropriate. So, what does this mean for the future of healthcare in Australia?
Antimicrobial resistance (AMR) occurs when bacteria, viruses, fungi, and parasites evolve to resist the medicines designed to combat them. This isn’t just a minor inconvenience—it’s a ticking time bomb that makes infections harder, and sometimes impossible, to treat. The AURA Report compiles data from 2022–2024 across hospitals, aged care facilities, and the broader community, painting the most detailed picture yet of how antibiotics are being used and where resistance is spreading fastest.
Here’s a startling fact: In 2024, 23.2 million antibiotic prescriptions were issued to about 37.1% of Australians under the Pharmaceutical Benefits Scheme, a 4.8% increase from 2023. Even more alarming, reports of critical antibiotic resistance jumped by 25.2% during the same period. This highlights the urgent need to preserve effective antimicrobials for community use.
Key takeaways from the report include:
- 88.1% of ‘last-line’ antibiotics (those reserved for the most severe infections) were prescribed appropriately in hospitals—a silver lining, but is it enough?
- Only 45.0% of antibiotics given post-surgery were considered appropriate, raising questions about prescribing practices.
- 14.4% more antimicrobials were prescribed to older Australians in residential aged care in 2024 compared to 2023.
- 34.7% of antibiotics in aged care were used for prolonged periods (over 6 months), potentially fueling resistance.
A CDC spokesperson emphasized the gravity of the situation: ‘The 25% increase in critical antimicrobial resistance cases and the inappropriate use of antibiotics post-surgery demand immediate, targeted action.’ While it’s encouraging that overall antibiotic use is down and ‘last-line’ antibiotics are still being carefully managed in hospitals, there’s a troubling trend: antibiotics perceived as lower risk are being overprescribed, even when there’s no clear benefit. Is this a case of better safe than sorry, or are we inadvertently fueling the resistance crisis?
The report also sheds light on the successes and gaps in antimicrobial stewardship programs. While many initiatives are working well, prescribing practices vary widely across settings, and improvements aren’t keeping pace with the rise of resistance. The AURA Report doesn’t introduce new policies but instead provides the critical evidence needed to guide stewardship, infection prevention, clinical guidelines, and future policy decisions.
‘National surveillance is our first line of defense,’ the CDC spokesperson added. ‘By identifying risks through concrete data, we can act before antimicrobial resistance becomes unstoppable.’
As Australia’s first national AMR report since the CDC’s establishment in 2026, the AURA Report is a cornerstone of the country’s long-term strategy to combat this growing threat. But the question remains: Are we doing enough, or are we on the brink of a post-antibiotic era?
What do you think? Is the current approach to antimicrobial stewardship sufficient, or do we need radical changes? Share your thoughts in the comments—this is a conversation we can’t afford to ignore.
For the full report, visit: https://www.amr.gov.au/resources/sixth-australian-report-antimicrobial-use-and-resistance-human-health-aura-report-0
